PRAME‑Targeted CAR‑T Immunotherapy Cures German Teen’s Metastatic Cancer
How a 17‑Year‑Old’s Immunotherapy Success Is Shaping the Future of Pediatric Cancer Care When Mailo Grühn from Thuringia was diagnosed with a malignant kidney tumor at age seven, doctors removed the primary growth and launched conventional chemotherapy. Two years later the disease had spread to his liver, spleen, lungs and brain. By early 2025, after … Read more